Edwards Lifesciences will release figures for the most recent quarter on April 25.Analysts expect earnings per share of $0.642.Go here to track ...

Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.62 With US$85.94 share price, ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $96.0, a high estimate of $105.00, ...

Edwards Lifesciences Corporation EW is scheduled to report first-quarter 2024 results on Apr 25, after market close. In the ...

Jim Mazzo is executive chairman of Neurotech, co-founder of local business accelerator Octane, and sits on numerous boards of ...

Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have ...

The upcoming report from Edwards Lifesciences (EW) is expected to reveal quarterly earnings of $0.64 per share, indicating an increase of 3.2% compared to the year-ago period. Analysts forecast ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Edwards Lifesciences said Tuesday that chair Michael Mussallem planned to retire about a year after stepping down as chief executive. The Irvine, Calif.-based company said in a regulatory filing ...

J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...